伟仕佳杰
Search documents
邦彦技术:与伟仕佳杰签订资金服务型总代理商合作协议
Xin Lang Cai Jing· 2026-01-12 09:09
Core Viewpoint - The company, Bangyan Technology (688132.SH), has signed a "Funding Service General Agent Cooperation Agreement" with Weishi Jiajie, which updates their previous strategic cooperation agreement and is expected to positively impact future performance if executed smoothly [1] Group 1 - The new agreement specifies the terms of cooperation based on the existing strategic partnership [1] - The original strategic cooperation agreement will become invalid upon the signing of the new agreement [1] - Actual procurement will be determined by the final signed "Product Order Form" between the two parties [1] Group 2 - Successful execution of the contract is anticipated to have a positive effect on the company's future performance [1] - There are potential risks and uncertainties during the agreement's implementation due to macroeconomic fluctuations and changes in industry policies [1]
晨雾笼罩三峡库区沿江小镇宛如云端仙境
Xin Lang Cai Jing· 2026-01-08 11:47
笼罩沿江小镇。杨孝永 摄 笼罩沿江小镇。杨孝永 摄 笼罩沿江小镇。杨孝永 摄 图为晨雾 1月8日,重庆美心红酒小镇迎来绝美晨雾景观。清晨,在重庆海拔最高的"乡村振兴之眼"摩天轮下,沿 江小镇被晨雾笼罩宛如云端仙境。杨孝永 摄 笼罩沿江小镇。杨孝永 摄 图为晨雾 图为晨雾 图为晨雾 ...
伟仕佳杰(00856.HK)1月2日耗资20.7万港元回购2.6万股
Ge Long Hui· 2026-01-02 09:34
格隆汇1月2日丨伟仕佳杰(00856.HK)发布公告,2026年1月2日耗资20.7万港元回购2.6万股,回购价格每 股7.97港元。 ...
伟仕佳杰(00856) - 翌日披露报表(股份购回)
2026-01-02 09:25
FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別: 股票 狀態: 新提交 公司名稱: 偉仕佳杰控股有限公司 呈交日期: 2026年1月2日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司(「香港聯交所」)證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露,必須填妥第一章節 。 | 第一章節 | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 00856 | 說明 | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | 已發行股份(不包括庫存股份)變動 | | | 庫存股份變動 | | | | | 事件 | 已發行股份(不包括庫存股份)數 目 | | 佔有關事 ...
伟仕佳杰(00856) - 截至2025年12月31日止之股份发行人的证券变动月报表
2026-01-02 09:09
股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年12月31日 狀態: 新提交 FF301 致:香港交易及結算所有限公司 公司名稱: 偉仕佳杰控股有限公司 呈交日期: 2026年1月2日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00856 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 2,000,000,000 | HKD | | 0.1 | HKD | | 200,000,000 | | 增加 / 減少 (-) | | | | | | | HKD | | | | 本月底結存 | | | 2,000,000,000 | HKD | | 0.1 | HKD | | 200,000,000 | 本月底 ...
苹果概念股普涨 招银国际预期明年苹果将迎来“创新大年”,偏好苹果供应链
Ge Long Hui· 2025-12-30 02:53
| 代码 | 名称 | 最新价 | 涨跌幅 √ | | --- | --- | --- | --- | | 01478 | 丘钛科技 | 8.440 | 2.93% | | 02382 | 舜宇光学科技 | 65.100 | 2.68% | | 06613 | 蓝思科技 | 24.620 | 2.07% | | 00856 | 伟仕佳杰 | 8.010 | 1.39% | | 00285 | 比亚迪电子 | 34.060 | 1.31% | | 02018 | 瑞声科技 | 38.940 | 1.41% | | 01415 | 高伟电子 | 27.120 | 0.67% | 港股频道更多独家策划、专家专栏,免费查阅>> 责任编辑:栎树 12月30日,港股苹果概念股普遍上涨,其中,丘钛科技涨3%,舜宇光学涨2.68%,蓝思科技涨2%,瑞 声科技、比亚迪电子、伟仕佳杰均上涨1.4%。 消息上,招银国际研究部副主管及科技行业分析师伍力恒表示,尽管受记忆体涨价及内地补贴红利退坡 影响,明年全球智能手机出货量预测按年下降5%,至11.8亿部,但苹果将迎来"创新大年",包括发布备 受期待的首部折叠屏手机,有助进一步巩固领 ...
港股异动丨苹果概念股普涨 招银国际预期明年苹果将迎来“创新大年”,偏好苹果供应链
Ge Long Hui· 2025-12-30 01:57
港股苹果概念股普遍上涨,其中,丘钛科技涨3%,舜宇光学涨2.68%,蓝思科技涨2%,瑞声科技、比 亚迪电子、伟仕佳杰均上涨1.4%。 该行看好立讯精密、鸿腾精密、比亚迪电子、舜宇光学、瑞声科技等供应商,料将受惠AI手机、AI眼 镜及AI伺服器的加速渗透,当中立讯精密、比亚迪电子来自苹果的收入占比均达到六成。 | 代码 | 名称 | 最新价 | 涨跌幅 √ | | --- | --- | --- | --- | | 01478 | 丘钛科技 | 8.440 | 2.93% | | 02382 | 舜宇光学科技 | 65.100 | 2.68% | | 06613 | 蓝思科技 | 24.620 | 2.07% | | 00856 | 伟仕佳杰 | 8.010 | 1.39% | | 00285 | 比亚迪电子 | 34.060 | 1.31% | | 02018 | 瑞声科技 | 38.940 | 1.41% | | 01415 | 高伟电子 | 27.120 | 0.67% | 消息上,招银国际研究部副主管及科技行业分析师伍力恒表示,尽管受记忆体涨价及内地补贴红利退坡 影响,明年全球智能手机出货量预测按年下降 ...
伟仕佳杰荣获“格隆汇金格奖·年度信息披露奖”
Ge Long Hui· 2025-12-23 10:03
格隆汇昨日线上举办"科技赋能·资本破局"分享会。备受瞩目的卓越公司评选榜单隆重揭晓。其中,格 隆汇"金格奖"年度卓越公司评选中,伟仕佳杰(0856.HK)荣获"年度信息披露奖"奖项。 "年度信息披露奖"旨在表彰资本市场中具备最佳信息披露能力的企业。信息披露是企业与投资者、社会 大众沟通的桥梁,良好的沟通总能加强双方的理解,推动企业走上更好的发展道路。本奖项从信息披露 的频繁度、准确性、及时性等多角度评选,甄选出的企业在交流沟通、信息披露、维护企业形象上取得 了丰硕成果。 ...
格隆汇“科技赋能·资本破局”线上分享会暨“金格奖”——“年度信息披露奖”奖项揭晓:复宏汉霖(02696.HK)、格科微(688728.SH)、康希诺生物(06185.HK)等6家企业上榜
Ge Long Hui· 2025-12-22 11:15
Core Insights - The "Golden Award" annual excellence company selection by Gelonghui will announce its results on December 22, highlighting companies recognized for their outstanding information disclosure capabilities [1][2] - Six companies, including Fuhong Hanlin, Gekewei, CanSino Biologics, TCL Technology, Weishi Jiajie, and Yonghe Medical, received the "Annual Information Disclosure Award" [1] Group 1 - The "Annual Information Disclosure Award" aims to recognize companies with the best information disclosure practices in the capital market [1] - Effective information disclosure serves as a bridge between companies and investors, enhancing mutual understanding and promoting better development paths for enterprises [1] - The evaluation criteria for the award include frequency, accuracy, and timeliness of information disclosure, with results derived from quantitative data analysis and expert review [1] Group 2 - Gelonghui's selection process aims to create a valuable reference list of listed companies and unicorns, covering all companies listed on major exchanges including HKEX, SSE, SZSE, NYSE, and NASDAQ [2]
伟仕佳杰(00856) - 2025 - 年度业绩
2025-12-19 08:31
Stock Repurchase and Treasury Shares - The company repurchased 4,978,000 shares of stock, holding 4,540,000 shares as treasury stock as of December 31, 2024[3]. - The company aims to maintain the same level of treasury shares for future resale or to fulfill share grant obligations[3]. Stock Option Plan - The total number of stock options available for issuance under the stock option plan is 152,542,799 shares, representing approximately 10.66% of the total issued shares as of the 2024 annual report date[4]. - No stock options were granted, exercised, canceled, or lapsed under the stock option plan during the year ending December 31, 2024[4]. - The average revenue growth rate for the fiscal years 2025-2027 must exceed 20% for stock options to vest, with a minimum threshold of 10% for partial vesting[5]. - The fair value of the stock options granted during the period is HKD 37,258,000, with an exercise price of HKD 7.25 per share[5]. - The total number of stock options available for issuance under the plan was zero at the end of the period due to the expiration of the stock option plan[5]. - The stock option plan was adopted on June 30, 2015, and has a remaining term of approximately 6 months as of December 31, 2024[4]. - The company has not granted any stock options since the adoption of the plan until December 31, 2024[5]. Governance Structure - The board of directors consists of both executive and independent non-executive members, ensuring a diverse governance structure[8].